Aurinia Pharmaceuticals AUPH
NASDAQ AUPH
$16.74 +0.25 (+1.52%)
At close: Oct 20, 2026 · 4:00 PM EDT

Aurinia Pharmaceuticals (AUPH) Restructuring Costs (2024 - 2025)

Updated

Aurinia Pharmaceuticals' Restructuring Costs was $1.65 million in FY2025, down 92.9% from $23.11 million in FY2024.

Analysis

Aurinia Pharmaceuticals (AUPH) Restructuring Costs (2024 - 2025) Analysis & Trends

  • Per Business Quant data, Restructuring Costs in earlier years was $23.11 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 Aurinia Pharmaceuticals 2.18 Bn 608.45 Mn 76.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 114,000.00
Mar 31, 2025 1.53 Mn
Dec 31, 2024 15.35 Mn
Jun 30, 2024 1.07 Mn
Mar 31, 2024 6.68 Mn
API Access

Aurinia Pharmaceuticals Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=AUPH&period=max&api_key=YOUR_API_KEY